Device Makers Weigh In On FDA Oversight Of Web Advertising
This article was originally published in The Gray Sheet
Executive Summary
Device companies should only be responsible for Web marketing content that they directly create or control, and should be allowed to use Web links to refer patients to information about product risks, AdvaMed and other industry stakeholders argue
You may also be interested in...
FDA Formula Allows Tweets About Products Without Excessive Risks
FDA’s draft guidance on presenting product information on social media platforms with character-space limitations includes an equation for sending a tweet. Solving it for products with complex risk profiles could be a challenge.
To Tweet Or Not To Tweet? Social Media Marketing Guidance Is There If You Look For It, Experts Say
Device and drug firms waiting for FDA to issue guidance on how best to use social media for marketing and promotion can look instead at existing regulations both in and outside the agency, experts said recently.
To Tweet Or Not To Tweet? Social Media Marketing Guidance Is There If You Look For It, Experts Say
Device and drug firms waiting for FDA to issue guidance on how best to use social media for marketing and promotion can look instead at existing regulations both in and outside the agency, experts said recently.